AU2001251761A1 - Equine protozoal myeloencephalitis vaccine - Google Patents

Equine protozoal myeloencephalitis vaccine

Info

Publication number
AU2001251761A1
AU2001251761A1 AU2001251761A AU5176101A AU2001251761A1 AU 2001251761 A1 AU2001251761 A1 AU 2001251761A1 AU 2001251761 A AU2001251761 A AU 2001251761A AU 5176101 A AU5176101 A AU 5176101A AU 2001251761 A1 AU2001251761 A1 AU 2001251761A1
Authority
AU
Australia
Prior art keywords
vaccine
equine protozoal
protozoal myeloencephalitis
myeloencephalitis
equine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251761A
Inventor
Rocky Barry Bigbie
Terry Kaleung Ng
Joseph Wilson Whalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2001251761A1 publication Critical patent/AU2001251761A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001251761A 2000-04-25 2001-04-13 Equine protozoal myeloencephalitis vaccine Abandoned AU2001251761A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19943500P 2000-04-25 2000-04-25
US60199435 2000-04-25
US27869501P 2001-03-26 2001-03-26
US60278695 2001-03-26
PCT/US2001/040527 WO2001080885A2 (en) 2000-04-25 2001-04-13 Equine protozoal myeloencephalitis vaccine

Publications (1)

Publication Number Publication Date
AU2001251761A1 true AU2001251761A1 (en) 2001-11-07

Family

ID=26894769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251761A Abandoned AU2001251761A1 (en) 2000-04-25 2001-04-13 Equine protozoal myeloencephalitis vaccine

Country Status (7)

Country Link
US (2) US7169398B2 (en)
EP (1) EP1276499A2 (en)
AR (1) AR035182A1 (en)
AU (1) AU2001251761A1 (en)
BR (1) BR0110232A (en)
CA (1) CA2407517A1 (en)
WO (1) WO2001080885A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
MXPA04011514A (en) 2002-05-21 2005-08-15 Pathogenes Inc Methods for the in vitro.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2917892A (en) * 1991-11-12 1993-06-15 Regents Of The University Of Minnesota Recombinant vaccine against lyme disease
CA2129514A1 (en) * 1992-03-12 1993-09-16 M. Amin Khan Controlled released acth containing microspheres
US6514697B1 (en) * 1992-05-29 2003-02-04 The Regents Of The University Of California Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6110665A (en) * 1995-02-14 2000-08-29 University Of Kentucky Research Foundation Sarcocystis neuronadiagnostic primer and its use in methods of equine protozoal myeloencephalitis diagnosis
GB2310212A (en) * 1996-02-16 1997-08-20 Jose Luis Azumendi Isolation of the sarcocystine toxin from the genus Sarcocystis
WO1997029120A1 (en) * 1996-02-05 1997-08-14 Sarco Research Corporation Limited Sarcocystine isolation
GB2310135A (en) * 1996-02-16 1997-08-20 Jose Luis Azumendi Sarcocystis vaccine:lyophilized bradyzoites
US5958414A (en) * 1997-09-03 1999-09-28 Heska Corporation Composition to protect a mammal against Bartonella henselae infection
US6071737A (en) * 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses
US7056517B2 (en) * 1998-04-13 2006-06-06 The Forsyth Institute Glucosyltransferase immunogens
US7163682B2 (en) * 1998-04-13 2007-01-16 The Forsyth Institute Glucan binding protein and glucosyltransferase immunogens
US6153394A (en) * 1998-09-18 2000-11-28 Board Of Trustees Operating Michigan State University Immunoassay for equine protozoal myeloencephalitis in horses
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
CA2359075A1 (en) * 1999-02-19 2000-08-24 Michigan State University An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
US6737237B1 (en) * 1999-05-04 2004-05-18 Apicomplexan Therapeutics, Llc Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components
AU7108700A (en) * 1999-09-02 2001-03-26 Michigan State University Vaccine to control equine protozoal myeloencephalitis in horses
US20070172502A1 (en) * 2000-02-07 2007-07-26 David Bzik Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
US7342101B1 (en) * 2003-12-01 2008-03-11 The University Of Texas System Board Of Regents Compositions and methods comprising a protective antigen of Coccidiodes immitis

Also Published As

Publication number Publication date
EP1276499A2 (en) 2003-01-22
AR035182A1 (en) 2004-05-05
WO2001080885A2 (en) 2001-11-01
BR0110232A (en) 2003-01-21
WO2001080885A3 (en) 2002-02-21
US7169398B2 (en) 2007-01-30
CA2407517A1 (en) 2001-11-01
US20070104739A1 (en) 2007-05-10
US20020041886A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
HK1064958A1 (en) Vaccine against hpv
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
AU1591402A (en) Vaccine
AP2002002424A0 (en) Vaccine
GB0014288D0 (en) Vaccine
AU5977700A (en) Vaccines
AU6158700A (en) Vaccine
AU2002249823A1 (en) Acne vaccine
GB0001475D0 (en) Virus strains
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
AU2001251761A1 (en) Equine protozoal myeloencephalitis vaccine
MXPA01010701A (en) Vaccine.
GB0025694D0 (en) Vaccine
AU5811600A (en) Vaccine
AU2002224845A1 (en) Viral expression system
GB0003082D0 (en) Vaccine
AU2001266534A1 (en) Papillomavirus vaccine
AU2001285421A1 (en) Vaccine against rsv
AU5084300A (en) New vaccine formulations - 1
AU2767201A (en) M cell directed vaccines
GB0006693D0 (en) Vaccine
GB0015722D0 (en) Vaccine